Sensei Biotherapeutics, Inc. - stock earnings
SNSE Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -7.4 million USD | 2.8 million USD |
2023Q3 | -7.1 million USD | ? USD |
2023Q2 | -9.4 million USD | ? USD |
2023Q1 | -8.9 million USD | ? USD |
2022Q4 | -12.4 million USD | ? USD |
2022Q3 | -12.9 million USD | ? USD |
2022Q2 | -10.4 million USD | ? USD |
2022Q1 | -12.3 million USD | ? USD |
2021Q4 | -9.4 million USD | ? USD |
2021Q3 | -9.7 million USD | ? USD |
2021Q2 | -9.8 million USD | ? USD |
2021Q1 | -8.0 million USD | ? USD |
2020Q4 | -5.1 million USD | ? USD |
2020Q3 | -5.4 million USD | ? USD |
2020Q2 | -4.9 million USD | ? USD |
2020Q1 | -4.7 million USD | ? USD |
2019Q4 | -6.7 million USD | ? USD |
SNSE Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -34.1 million USD | ? USD |
2022 | -48.8 million USD | ? USD |
2021 | -37.5 million USD | ? USD |
2020 | -20.6 million USD | ? USD |
2019 | -19.0 million USD | ? USD |
2018 | -13.0 million USD | ? USD |
SNSE
Price: $1.84
52 week price:
Earnings Per Share: -1.22 USD
P/E Ratio: -0.61
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 18884
Market Capitalization: 27.9 million